As has been the answer to all things Covid, the solution is more Covid injections as people are being encouraged to get a “booster.”
A booster of the same injections of which some people have had two or three. If those are not protecting people from being infected with or transmitting Covid, why would the third or the fourth?
ioNTech co-developed a Covid-19 injection with America’s Pfizer. On 23 August 2021, the US Food and Drug Administration (“FDA”) announced the first approval of a Covid-19 injection: “The vaccine has been known as the Pfizer-BioNTech Covid-19 vaccine, and will now be marketed as Comirnaty.”
BioNTech co-founder [and CEO] Ugur Sahin said in an interview published Tuesday that while the omicron variant may result in more breakthrough cases of COVID-19, most vaccinated individuals will likely experience mild illness.
But only a few days before the Helsinki Times reported “the pharmaceutical companies Pfizer and BioNTech on Saturday issued a statement stating that they are not sure whether their vaccines would be able to help in the treatment of the new Covid-19 variant ‘Omicron’ … The pharmaceutical companies underscored that they started working on making their vaccine adaptable to new possible variants months ago.”
Sahin said,”Our message is: Don’t freak out, the plan remains the same: Speed up the administration of a third booster shot.”
In early November, shares of BioNTech took a dramatic 20% plunge in the wake of a damning whistle-blower report. The whistle-blower, Brook Jackson, claimed that the company hired poorly-trained vaccinators, that it was slow to investigate the injections adverse effects and even falsified data on the trials. She provided the British Medical Journal with dozens of internal documents to substantiate her claims.
By the third week of November, Sahin said in an interview that people around the world will need to get an injection against Covid-19 once a year, at least when it comes to the Pfizer “vaccine.” We have to wonder if the push for more “vaccines” is related to bolstering BioNTech’s share price.
In addition to the whistle-blower’s revelations the efficacy of the injections as claimed by the trials has been brought into question. The randomised controlled method was applied to the Pfizer-BioNTech “vaccine” trials but Pfizer designed the trial, and they are highly experienced in setting up trials for success. ...<<<Read More>>>...
